Cite
HARVARD Citation
Wollenhaupt, J. et al. (n.d.). THU0179 Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-label, Long-term Extension up to 6 Years. Annals of the rheumatic diseases. p. 259. [Online].